Renal function should be checked if prolonged gastrointestinal symptoms occur, especially in those with existing kidney disease For injection site reactions: Rotate injection sites (abdomen, thigh, upper arm) to prevent localised irritation Allow the medication to reach room temperature before injecting Use proper injection technique as demonstrated by your healthcare provider Important safety considerations: Women using oral contraceptives should use non-oral or barrier methods for 4 weeks after starting tirzepatide and after each dose increase, as absorption may be affected [1] If you are taking insulin or sulphonylureas, your doctor may need to reduce these doses to prevent hypoglycaemia Report symptoms of gallbladder disease (severe right upper abdominal pain, jaundice) promptly Attend all scheduled follow-up appointments to monitor glycaemic control, weight, and overall tolerability Report any new, persistent, or worsening symptoms to your healthcare team promptly Do not discontinue Mounjaro without consulting your prescriber, as abrupt cessation may affect diabetes control Be aware of signs of pancreatitis (severe, persistent abdominal pain radiating to the back) and seek immediate medical attention if these occur Your healthcare provider can offer personalised advice based on your individual circumstances, comorbidities, and treatment goals
Individuals with a history of failed weight loss attempts and those committed to long-term lifestyle changes are the best candidates for this therapy
Review medications If youre on drugs that deplete folate/B12, discuss alternatives with your doctor
Posted by Robert RatliffClient Alert HHS Accessibility Requirements for Medical Diagnostic Equipment: What Health Care Providers Need to Know July 8, 2026Health care providers that receive federal financial assistance are now subject to updated HHS accessibility requirements for medical diagnostic equipment under Section 504 of the Rehabilitation Act
